Haemonetics Corp (HAE)
95.90
+3.30
(+3.56%)
USD |
NYSE |
May 10, 16:00
95.90
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Price to Book Value: 5.163 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 4.985 |
| May 08, 2024 | 5.020 |
| May 07, 2024 | 5.125 |
| May 06, 2024 | 5.135 |
| May 03, 2024 | 5.082 |
| May 02, 2024 | 5.025 |
| May 01, 2024 | 4.960 |
| April 30, 2024 | 4.950 |
| April 29, 2024 | 4.926 |
| April 26, 2024 | 4.899 |
| April 25, 2024 | 4.719 |
| April 24, 2024 | 4.642 |
| April 23, 2024 | 4.58 |
| April 22, 2024 | 4.502 |
| April 19, 2024 | 4.374 |
| April 18, 2024 | 4.493 |
| April 17, 2024 | 4.570 |
| April 16, 2024 | 4.532 |
| April 15, 2024 | 4.570 |
| April 12, 2024 | 4.588 |
| April 11, 2024 | 4.658 |
| April 10, 2024 | 4.638 |
| April 09, 2024 | 4.687 |
| April 08, 2024 | 4.593 |
| April 05, 2024 | 4.557 |
| Date | Value |
|---|---|
| April 04, 2024 | 4.570 |
| April 03, 2024 | 4.518 |
| April 02, 2024 | 4.532 |
| April 01, 2024 | 4.565 |
| March 28, 2024 | 4.595 |
| March 27, 2024 | 4.527 |
| March 26, 2024 | 4.395 |
| March 25, 2024 | 4.405 |
| March 22, 2024 | 4.322 |
| March 21, 2024 | 4.323 |
| March 20, 2024 | 4.297 |
| March 19, 2024 | 4.173 |
| March 18, 2024 | 4.080 |
| March 15, 2024 | 4.028 |
| March 14, 2024 | 4.070 |
| March 13, 2024 | 4.11 |
| March 12, 2024 | 4.138 |
| March 11, 2024 | 4.219 |
| March 08, 2024 | 4.286 |
| March 07, 2024 | 4.186 |
| March 06, 2024 | 4.170 |
| March 05, 2024 | 4.119 |
| March 04, 2024 | 4.026 |
| March 01, 2024 | 3.993 |
| February 29, 2024 | 3.929 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.061
Minimum
Jan 27 2022
11.90
Maximum
Aug 16 2019
6.382
Average
5.266
Median
Oct 03 2022
Price to Book Value Benchmarks
| Stryker Corp | 6.568 |
| ResMed Inc | 6.784 |
| Masimo Corp | 4.738 |
| Insulet Corp | 15.84 |
| InfuSystems Holdings Inc | 2.968 |
Price to Book Value Related Metrics
| PE Ratio | 38.98 |
| PS Ratio | 3.877 |
| PEG Ratio | 1.182 |
| Price to Free Cash Flow | 38.25 |
| Price | 95.90 |
| Earnings Yield | 2.57% |
| Market Cap | 4.870B |
| PEGY Ratio | 1.182 |
| Operating PE Ratio | 27.32 |
| Normalized PE Ratio | 36.78 |